Development of Medication Adherence tool for select NCDs in Indian populatio
Not Applicable
- Conditions
- Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 3: I10- Essential (primary) hypertensionHealth Condition 4: J452- Mild intermittent asthmaHealth Condition 5: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2023/11/059643
- Lead Sponsor
- ICMR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Select NCD patients (T2 Diabetes on OHA, hypertension, CAD, COPD/Bronchial Asthma) on drug treatment for at least 1 year
Age above 18 years
Exclusion Criteria
Presence of any cognitive and psychological disorders and debilitating illness that interfere with the responsiveness
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary Endpoints <br/ ><br>Psychometric properties such as Sensitivity, specificity, CVI, CVR, Cronbach’s alpha & factor structure of the tool <br/ ><br>ROC curve for determining cut off score between adherent & non-adherent participants <br/ ><br>Secondary Endpoints <br/ ><br>Qualitative study for Determinants of medication adherence from provider Doctors, pharmacist, nurses, programme officer) & end user perspectives <br/ ><br>Cross sectional study for Prevalence estimates of adherence for the conditions studied <br/ ><br>Timepoint: Qualitative study starts at eighth month & last for six months <br/ ><br>cognitive piloting starts at sixteenth month and last for 2 months <br/ ><br>survey administration for scale development starts at eighteenth month and last for 2 months <br/ ><br>cross sectional study starts at 24 months and last for seven months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Secondary Endpoints <br/ ><br>Qualitative study for Determinants of medication adherence from provider Doctors, pharmacist, nurses, programme officer) & end user perspectives <br/ ><br>Cross sectional study for Prevalence estimates of adherence for the conditions studied <br/ ><br>Timepoint: Qualitative study starts at eighth month & last for six months <br/ ><br>cross sectional study starts at 24 months and last for seven months <br/ ><br>